|
| Press Releases |
|
 |
|
| Wednesday, February 22, 2023 |
|
|
Essex and Henlius signed amendment agreement for Global Co-Development and Exclusive License Agreement for treatment of age-related macular degeneration |
| Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced that two of its wholly-owned subsidiaries, Essex Bio-Investment Limited ("Essex Bio-Investment") and Zhuhai Essex Bio-Pharmaceutical Co. Ltd ("Zhuhai Essex") more info >> |
|
| Friday, February 10, 2023 |
|
|
First Patient in the US Dosed in a Global Multicentre Phase 3 Clinical Study of Bevacizumab for treatment of Ophthalmic Diseases |
| Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced that the first patient in the United States (US) was dosed in a global multi-centre phase 3 clinical trial (NCT04740671) of EB12-20145P (HLX04-O), a recombinant anti-VEGF humanised monoclonal antibody injection jointly developed by the Group and Shanghai Henlius Biotech, Inc. more info >> |
|
| Thursday, October 13, 2022 |
|
|
Essex Biotechnology Secures Exclusive Rights and Interests in SkQ1 for Ophthalmology from Mitotech |
| Essex Bio-Technology Ltd (Essex Bio-Technology; HKG: 1061) wishes to announce that wholly-owned subsidiary Essex Bio-Investment Ltd (Essex Bioinvestment) on 13 October 2022 successfully secured (i) a patent and know-how licence agreement; and (ii) a patent assignment deed in relation to SkQ1, an active pharmaceutical ingredient, from Mitotech S.A. more info >> |
|
| Tuesday, August 16, 2022 |
|
|
Essex Bio-Technology Included in "Forbes Asia's Best Under A Billion 2022" |
| Essex Bio-Technology Ltd ("EssexBio" or the "Group", Stock Code: 1061.HK) is pleased and honoured to announce that it is included in "Forbes Asia's 200 Best Under A Billion 2022" - for the Group's outstanding long-term sustainable development across a variety of metrics. more info >> |
|
| Tuesday, March 22, 2022 |
|
|
Essex Bio-Technology Announces 2021 Financial Results |
| Essex Bio-Technology Ltd ("Essex" or the "Group", Stock Code: 1061.HK) today announced the annual results for the year ended 31 December 2021. more info >> |
|
|
|
|
|
|
|
|
 |
| Latest Press Releases |
|
Formerra Appoints Tom Kelly as Chief Executive Officer 
Mar 5, 2026 14:24 HKT/SGT
|
|
|
Hong Kong International Jewellery Show opens today showcasing global designs and trends
Mar 5, 2026 13:49 HKT/SGT
|
|
|
Core Concepts Physiotherapy Partners with Podiatry Quest to Deliver Enhanced Assessments for Patients with Plantar Fasciitis
Mar 5, 2026 12:30 HKT/SGT
|
|
|
FinHarbor Completes Core Deployment of Hybrid Neobank Platform for Asterium in Uzbekistan
Mar 5, 2026 08:20 HKT/SGT
|
|
|
Philippine Hotel Innovation Summit 2026 Concludes in Manila, Setting a New Blueprint for the Future of Hospitality
Mar 4, 2026 20:07 HKT/SGT
|
|
|
BASIS Accelerates Platform Development Following $35M Capital Injection
Mar 4, 2026 19:00 HKT/SGT
|
|
|
Thailand RISE Fund Positions Thai Research for Global Innovation Impact
Mar 4, 2026 14:59 HKT/SGT
|
|
|
JCB, together with Resona, Realize a New Purchasing Experience: The World's First Full-Scale Project to Commercialize Ultra-Wideband (UWB) Payments
Mar 4, 2026 09:00 HKT/SGT
|
|
|
OMP Unveils Decision-Centric Planning to Accelerate Supply Chain Decision Velocity
Mar 3, 2026 21:00 HKT/SGT
|
|
|
TANAKA Establishes Transfer Technology for its Sintered Gold (Au) Bonding Technology "AuRoFUSE(TM) Preforms"
Mar 3, 2026 22:00 JST
|
|
|
MMG Announces 2025 Anuual Results, Record results, strong momentum
Mar 3, 2026 20:18 HKT/SGT
|
|
|
Fujitsu and BCN Port Innovation Foundation leverage ocean digital twin technology to drive the regeneration of the Port of Barcelona
Mar 3, 2026 21:00 JST
|
|
|
Hua Medicine Announces the Approval of Dorzagliatin for Marketing in Hong Kong SAR, China
Mar 3, 2026 12:14 HKT/SGT
|
|
|
Concord New Energy Signs MOU with Bain Capital-Backed Bridge Data Centre
Mar 3, 2026 09:03 HKT/SGT
|
|
|
Affiliate of Pacific Avenue Capital Partners to Acquire Care.com from IAC
Mar 3, 2026 08:00 HKT/SGT
|
|
|
|
|
More Press release >> |
|
|
|
|
|
|
|
